Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yoshiko Azuma

Evaluation of Azacitidine in Patients With Transplant‑ineligible Myelodysplastic Syndromes and Acute Myeloid Leukemia With Myelodysplasia‑related Changes in a Japanese Clinical Setting

Oncology Letters

Cancer Research

Oncology

2019

English

Related publications

BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Frontiers in Oncology

Cancer Research

Oncology

2019

English

Therapy-Related Myelodysplasia and Acute Myeloid Leukemia

English

Successful Treatment of Behçet's Disease Associated With Acute Myeloid Leukemia With Myelodysplasia-Related Changes Using Azacitidine and Tacrolimus Before Allogeneic Hematopoietic Stem Cell Transplantation

Internal Medicine

Medicine

2017

English

Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of Myelodysplasia

Clinical Lymphoma, Myeloma and Leukemia

English

Assessment of Treatment-Related Myelodysplastic Syndromes and Acute Myeloid Leukemia in Patients With Non-Hodgkin Lymphoma Treated With Tositumomab and Iodine I131 Tositumomab

English

Allogeneic Stem Cell Transplantation in Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndromes: Impact of Patient Characteristics and Timing of Transplant

Leukemia and Lymphoma

English

CD30 Expression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes

Clinical Lymphoma, Myeloma and Leukemia

English

Phase I Dose Escalation Study of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

English

Interest of the Association Azacitidine–lenalidomide as Frontline Therapy in High-Risk Myelodysplasia or Acute Myeloid Leukemia With Complex Karyotype

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yoshiko Azuma

Evaluation of Azacitidine in Patients With Transplant‑ineligible Myelodysplastic Syndromes and Acute Myeloid Leukemia With Myelodysplasia‑related Changes in a Japanese Clinical Setting

Related publications

BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Therapy-Related Myelodysplasia and Acute Myeloid Leukemia

Successful Treatment of Behçet's Disease Associated With Acute Myeloid Leukemia With Myelodysplasia-Related Changes Using Azacitidine and Tacrolimus Before Allogeneic Hematopoietic Stem Cell Transplantation

Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of Myelodysplasia

Assessment of Treatment-Related Myelodysplastic Syndromes and Acute Myeloid Leukemia in Patients With Non-Hodgkin Lymphoma Treated With Tositumomab and Iodine I131 Tositumomab

Allogeneic Stem Cell Transplantation in Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndromes: Impact of Patient Characteristics and Timing of Transplant

CD30 Expression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes

Phase I Dose Escalation Study of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Interest of the Association Azacitidine–lenalidomide as Frontline Therapy in High-Risk Myelodysplasia or Acute Myeloid Leukemia With Complex Karyotype